<bill session="110" type="s" number="573" updated="2013-07-19T22:25:16-04:00">
  <state datetime="2007-02-13">REFERRED</state>
  <status>
    <introduced datetime="2007-02-13"/>
  </status>
  <introduced datetime="2007-02-13"/>
  <titles>
    <title as="introduced" type="short">Heart Disease Education, Analysis and Research, and Treatment for Women Act</title>
    <title as="introduced" type="short">HEART for Women Act</title>
    <title as="introduced" type="official">A bill to amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women.</title>
  </titles>
  <sponsor id="300093"/>
  <cosponsors>
    <cosponsor id="300001" joined="2007-02-13"/>
    <cosponsor id="300006" joined="2007-06-18"/>
    <cosponsor id="300009" joined="2007-06-25"/>
    <cosponsor id="300011" joined="2007-02-26"/>
    <cosponsor id="400050" joined="2007-09-18"/>
    <cosponsor id="300016" joined="2008-03-06"/>
    <cosponsor id="300018" joined="2007-04-19"/>
    <cosponsor id="400064" joined="2007-06-25"/>
    <cosponsor id="412246" joined="2007-03-21"/>
    <cosponsor id="300021" joined="2008-02-28"/>
    <cosponsor id="300022" joined="2007-04-23"/>
    <cosponsor id="300023" joined="2007-02-13"/>
    <cosponsor id="300024" joined="2007-05-25"/>
    <cosponsor id="300025" joined="2007-02-13"/>
    <cosponsor id="300026" joined="2007-04-25"/>
    <cosponsor id="300027" joined="2008-02-04"/>
    <cosponsor id="300034" joined="2007-07-24"/>
    <cosponsor id="300035" joined="2007-04-24"/>
    <cosponsor id="300036" joined="2007-05-14"/>
    <cosponsor id="300037" joined="2007-02-14"/>
    <cosponsor id="300038" joined="2007-04-24"/>
    <cosponsor id="300043" joined="2007-04-20"/>
    <cosponsor id="300054" joined="2007-04-24"/>
    <cosponsor id="300056" joined="2008-02-06"/>
    <cosponsor id="400194" joined="2008-02-05"/>
    <cosponsor id="300058" joined="2007-06-14"/>
    <cosponsor id="300060" joined="2008-05-08"/>
    <cosponsor id="412242" joined="2007-04-20"/>
    <cosponsor id="300063" joined="2007-04-24"/>
    <cosponsor id="300064" joined="2007-04-10"/>
    <cosponsor id="300066" joined="2007-03-19"/>
    <cosponsor id="300067" joined="2007-03-09"/>
    <cosponsor id="300068" joined="2007-04-24"/>
    <cosponsor id="412243" joined="2007-04-24"/>
    <cosponsor id="400272" joined="2007-02-13"/>
    <cosponsor id="300073" joined="2007-04-19"/>
    <cosponsor id="300075" joined="2007-02-13"/>
    <cosponsor id="300076" joined="2007-04-18"/>
    <cosponsor id="400629" joined="2008-05-19"/>
    <cosponsor id="300080" joined="2007-09-06"/>
    <cosponsor id="400357" joined="2007-03-06"/>
    <cosponsor id="300087" joined="2007-05-14"/>
    <cosponsor id="300091" joined="2007-02-13"/>
    <cosponsor id="412244" joined="2007-03-13"/>
    <cosponsor id="400546" joined="2008-02-29"/>
    <cosponsor id="412247" joined="2007-04-10"/>
    <cosponsor id="300100" joined="2008-07-24"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2007-02-13">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral, In Committee"/>
  </committees>
  <relatedbills>
    <bill relation="identical" session="110" type="h" number="1014"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Access to health care"/>
    <term name="Administrative procedure"/>
    <term name="Cardiovascular diseases"/>
    <term name="Clinical trials"/>
    <term name="Commerce"/>
    <term name="Communication in medicine"/>
    <term name="Communication in science"/>
    <term name="Congress"/>
    <term name="Congressional investigations"/>
    <term name="Congressional reporting requirements"/>
    <term name="Data banks"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Education"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Government publicity"/>
    <term name="Governmental investigations"/>
    <term name="Health education"/>
    <term name="Health information systems"/>
    <term name="Health surveys"/>
    <term name="Higher education"/>
    <term name="Hospital care"/>
    <term name="Indian medical care"/>
    <term name="Indian women"/>
    <term name="Law"/>
    <term name="Licenses"/>
    <term name="Medical education"/>
    <term name="Medical malpractice"/>
    <term name="Medical records"/>
    <term name="Medical screening"/>
    <term name="Medical statistics"/>
    <term name="Medical supplies"/>
    <term name="Medical tests"/>
    <term name="Medically uninsured"/>
    <term name="Medicare"/>
    <term name="Minorities"/>
    <term name="Minority health"/>
    <term name="Native Americans"/>
    <term name="Peer review organizations (Medicine)"/>
    <term name="Pharmaceutical research"/>
    <term name="Physicians"/>
    <term name="Poverty"/>
    <term name="Preventive medicine"/>
    <term name="Quality of care"/>
    <term name="Science, technology, communications"/>
    <term name="Social welfare"/>
    <term name="Standards"/>
    <term name="Stroke"/>
    <term name="Women"/>
    <term name="Women's health"/>
  </subjects>
  <amendments/>
  <summary>2/13/2007--Introduced.
Heart Disease Education, Analysis Research, and Treatment for Women Act or the HEART for Women Act - Amends the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to require an application for approval or for investigation of a drug, device, or biological product to include information stratified by sex, race, and ethnicity, including any differences in safety and effectiveness. Requires the Secretary of Health and Human Services to: (1) withhold approval of such an application or place a clinical hold on an investigation if such information is not included; and (2) report to the scientific community and make information available to the public on such stratified data upon approval of an application.Requires the Comptroller General to study the drug approval process to ensure compliance with this Act.Requires the Secretary to require that all nonidentifiable patient safety work product reported to a patient safety database be stratified by sex. Requires the Secretary, acting through the Director of the Agency for Healthcare Research and Quality (AHRQ), to report to Congress concerning the quality of and access to care for women with heart disease, stroke, and other cardiovascular diseases.Provides for an educational campaign relating to heart disease, stroke, and cardiovascular diseases in women.Authorizes appropriations to enable the Director of the Centers for Disease Control and Prevention to implement Well-Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) program projects in all states and territories.</summary>
</bill>
